Dr. Kalac is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-880-7812Fax+1 212-731-5210
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2013 - 2016
NYU Grossman School of MedicineResidency, Internal Medicine, 2011 - 2013
University of Zagreb Faculty of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2022 - 2026
NY State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 91 citationsA phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphomaJennifer E Amengual, Renee Lichtenstein, Jennifer K. Lue, Ahmed Sawas, Changchun Deng
Blood. 2018-01-25 - 47 citationsSirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphomaJennifer E Amengual, Sean Clark-Garvey, Matko Kalac, Luigi Scotto, Enrica Marchi
Blood. 2013-09-19 - 47 citationsThe combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma.Enrica Marchi, Kelly Zullo, Jennifer E Amengual, Matko Kalac, Danielle C Bongero
British Journal of Haematology. 2015-10-01
Journal Articles
- Brentuximab Vedotin and Bendamustine Produce High Complete Response Rates in Patients with Chemotherapy Refractory Hodgkin LymphomaChangchun Deng, Markus Y. Mapara, Ahmed Sawas, Matko Kalac, British Journal of Haematology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
